Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
It also helps reduce markers of metabolic stress
At 68 weeks, patients on retatrutide 12 mg lost an average of 28.7% of their body weightequivalent to 71.2 lbs (32.3 kg) from a baseline weight of around 248 lbs
Andersen, Frederik
No other peptide in development has matched these results
Complete List of FDA-Approved GLP-1 Medications (2026) Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 agonist technically not a pure GLP-1 drug, but clinically grouped in the same class due to mechanism overlap and similar prescribing patterns
US$ 24.66
US$ 21.67
US$ 27.34
US$ 24.64
US$ 22.36
